Phased Avelumab combined with chemotherapy as first-line treatment for patients with advanced small-cell lung cancer (SCLC)
Phase of Trial: Phase II
Latest Information Update: 07 Feb 2019
Price : $35 *
At a glance
- Drugs Avelumab (Primary) ; Carboplatin; Cisplatin; Etoposide
- Indications Small cell lung cancer
- Focus Therapeutic Use
- Acronyms PAVE
- 06 Nov 2018 Status changed from not yet recruiting to recruiting.
- 01 Aug 2018 Planned initiation date changed from 1 Jun 2018 to 1 Oct 2018.
- 30 Apr 2018 New trial record